The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CAGR of 6.59% during the forecast period (2025-2033).
A bladder scanner is a non-invasive medical device that utilizes ultrasound technology to measure the volume of urine in the bladder. By generating detailed images of the bladder, it enables healthcare providers to assess its contents without resorting to catheterization. This makes it particularly valuable for diagnosing conditions like urinary retention, monitoring bladder function, and guiding treatments for issues such as incontinence or post-surgical care. The scanner offers a quick, painless, and accurate way to evaluate bladder health, helping determine whether a patient needs to void or if further medical intervention is necessary.
The bladder scanner market is experiencing significant growth, driven by several factors. The increasing prevalence of urological disorders, coupled with a growing aging population facing urination-related issues, is one key driver. Technological advancements are also playing a crucial role, enhancing the capabilities and accessibility of these devices. Moreover, the rising demand for non-invasive diagnostic tools is pushing the market forward as more patients and healthcare providers seek alternative methods to traditional procedures like catheterization.
Supportive regulatory policies, government initiatives, and strategic collaborations are also contributing to the market’s expansion, ensuring broader availability and adoption of bladder scanners across healthcare settings.
The integration of artificial intelligence (AI) is transforming bladder scanners into more advanced diagnostic tools, leading to improved outcomes. AI-powered bladder scanners offer clinicians enhanced flexibility, enabling them to perform ultrasound-guided bladder scanning with a single device. This innovation streamlines the scanning process, making it faster and more efficient.
The inclusion of AI accelerates the scanning process and enhances diagnostic accuracy, significantly driving market growth.
Traditional bladder scanners are typically bench-mounted, consisting of a separate scanner and display that require space and careful handling. To address these limitations, handheld bladder scanners have been introduced, offering a more compact, integrated solution that combines the scanner and display in a single device. This eliminates the complexities associated with traditional systems, providing a more streamlined and portable option for healthcare providers.
The introduction of handheld bladder scanners enhances the speed and ease of diagnosis, further accelerating market growth.
The rising prevalence of urological diseases is a significant driver of market growth, as there is an increasing demand for accurate and early diagnosis of these conditions. Common urological disorders such as urinary tract infections (UTIs), benign prostatic hyperplasia (BPH), and urolithiasis require detailed diagnosis to ensure effective treatment. Bladder scanning plays a crucial role in this process, providing healthcare providers with a non-invasive and efficient tool for assessing bladder function and identifying underlying issues.
Below graph represents the number of cases of various urological diseases in 2021
Source: Published Article & Straits Research
As these diseases become more prevalent, the need for bladder scanners to aid in diagnosis and monitoring continues to rise, propelling market expansion.
Ongoing research and development in bladder scanner chip technology are playing a pivotal role in driving market growth by facilitating the launch of new, innovative products. These advancements have led to the introduction of a wide range of bladder scanners, each featuring different technologies designed to meet varying diagnostic needs.
As these technological breakthroughs continue to shape the market, they are driving both product variety and innovation, ensuring the continued growth of the bladder scanners market.
The significant cost of bladder scanners remains a key challenge to the market’s growth, particularly from the perspective of end users. The initial investment required for acquiring these devices can be prohibitively high, limiting their accessibility and adoption across healthcare settings.
On average, a bladder scanner can cost between $3,000 and $6,000, with some models reaching prices of $24,000 or more. This high upfront cost deters many healthcare providers, particularly smaller clinics or those in developing regions, from purchasing the devices. Thus, the substantial financial barrier slows the widespread adoption and growth of the global market.
The increasing recognition of bladder scanners as a vital tool for urological diagnostics presents significant market opportunities, especially with growing government support. As urinary-related issues often affect other bodily systems, governments are increasingly focusing on the importance of early detection through non-invasive diagnostic tools like bladder scanners. To promote better healthcare and prevent avoidable complications, many governments are providing funding to support the adoption of bladder scanners.
This type of funding reflects a broader trend of governmental investment in bladder scanning technology, signaling the potential for continued market growth.
| Study Period | 2021-2033 | CAGR | 6.59% |
| Historical Period | 2021-2023 | Forecast Period | 2025-2033 |
| Base Year | 2024 | Base Year Market Size | USD 149.28 million |
| Forecast Year | 2033 | Forecast Year Market Size | USD 270.46 million |
| Largest Market | North America | Fastest Growing Market | Asia-Pacific |
North America holds the largest revenue share in the global bladder scanners industry, driven by several key factors. The region’s dominance is attributed to the rising prevalence of urological conditions, such as urinary tract infections (UTIs) and benign prostatic hyperplasia (BPH), alongside increased healthcare spending and robust investments in research and development.
Companies in North America are also integrating cutting-edge features, such as artificial intelligence and 3D imaging, into bladder scanners, enhancing diagnostic accuracy and efficiency.
Asia Pacific is expected to experience the fastest CAGR in the global market for bladder scanners. Key factors driving this growth include significant investments in healthcare infrastructure, increasing research and development for innovative product launches, and the rising prevalence of urological diseases.
This technological advancement highlights the region's focus on improving diagnostic tools, particularly in urology, and demonstrates the growing demand for efficient, non-invasive devices in Asia Pacific’s expanding healthcare sector.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global bladder scanners market is segmented into product type, application, and end-user.
The handheld bladder scanner segment leads the market, driven by its ease of use, portability, and technological advancements that provide quick, accurate results. Compared to traditional bench-mounted systems, handheld devices offer healthcare providers greater flexibility and efficiency. In September 2024, GE Healthcare introduced an advanced tablet-based ultrasound system, further enhancing the appeal of handheld solutions. This convenience and innovation are propelling the handheld bladder scanner segment to dominate market revenue.
The urology segment holds the largest market share due to the widespread need for bladder scanning in diagnosing various urological diseases. Conditions like benign prostatic hyperplasia (BPH) and urinary tract infections (UTIs) require early and accurate diagnosis, driving demand for bladder scanners. According to the NIH, the global prevalence of UTIs and BPH in 2021 was 2,782.59 and 5,531.88 cases per 100,000 persons, respectively, underscoring the significance of bladder scanners in urology diagnostics.
The diagnostic centers segment dominates the bladder scanner market due to their critical role in disease diagnosis. These centers are equipped with a wide range of diagnostic tools, including bladder scanners, to identify urological, gynecological, and spinal cord-related conditions. Since diagnostic centers specialize in diagnosing various medical conditions, they represent a significant portion of market revenue. Their concentrated focus on diagnostic services makes them the largest end-user segment in the bladder scanner market.
In the bladder scanner market, there is competition between several key players. Becton Dickinson and Company, dBMEDx Inc., Vitacon, Laborie Medical Technologies Inc., GE Healthcare Inc., EchoNous, Inc., SRS Medical Systems, and Roper Technologies, Inc. are some prominent names in this industry. Becton, Dickinson, and Company (BD) stand out as a major player, offering the BBS Revolution bladder scanner that utilizes ultrasound energy to generate bladder images.
Another noteworthy development comes from Withings, recognized for its health-focused consumer tech. At CES 2023, they unveiled the U-Scan, described as the "first hands-free connected home urine lab." This device allows users to conveniently monitor urine composition without the hassle of cups or test strips. It seamlessly integrates with the Health Mate app, providing valuable insights. Clarius Mobile Health, a global leader in wireless ultrasound solutions, has received FDA clearance for its Clarius Bladder AI. This non-invasive tool can swiftly measure bladder volume, enhancing efficiency in healthcare settings. The industry is dedicated to creating user-friendly, technologically advanced bladder scanning solutions for improved patient outcomes and enhanced ease of use for healthcare professionals.
As per our analyst, the global market is poised for significant growth, driven by rising incidences of urological disorders and an aging global population. The increasing preference for non-invasive diagnostic tools in healthcare is bolstering the demand for bladder scanners, especially in urology clinics and hospitals.
Technological advancements, such as portable and 3D ultrasound-enabled scanners, are enhancing diagnostic accuracy and usability, further fueling market expansion. Moreover, the growing awareness about urinary health and government initiatives to improve healthcare infrastructure in emerging economies are creating lucrative opportunities for manufacturers.
However, challenges such as high device costs and limited accessibility in remote regions may hinder adoption. Overall, the market is set to experience steady growth in the coming years.
